CATALOGO DEI PRODOTTI DELLA RICERCA

Carbognin, Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.896
NA - Nord America 1.572
AS - Asia 1.170
SA - Sud America 141
AF - Africa 25
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.547
RU - Federazione Russa 855
CN - Cina 434
SG - Singapore 424
GB - Regno Unito 362
SE - Svezia 130
IT - Italia 129
DE - Germania 121
BR - Brasile 108
HK - Hong Kong 101
IE - Irlanda 97
VN - Vietnam 86
FR - Francia 83
FI - Finlandia 46
KR - Corea 31
NL - Olanda 23
JP - Giappone 22
IN - India 17
UA - Ucraina 17
AR - Argentina 10
CA - Canada 10
MX - Messico 8
PL - Polonia 8
ZA - Sudafrica 8
TR - Turchia 7
BD - Bangladesh 6
EC - Ecuador 6
ID - Indonesia 6
UZ - Uzbekistan 6
MA - Marocco 5
PK - Pakistan 5
VE - Venezuela 5
ES - Italia 4
BJ - Benin 3
BO - Bolivia 3
IQ - Iraq 3
IR - Iran 3
PY - Paraguay 3
SA - Arabia Saudita 3
TG - Togo 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AT - Austria 2
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
HT - Haiti 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TN - Tunisia 1
WS - Samoa 1
Totale 4.808
Salva come PNG Salva come JPEG
Città #
Southend 328
Moscow 307
Chandler 263
Singapore 193
Woodbridge 133
Dallas 126
Ashburn 115
Beijing 98
Hong Kong 98
Dublin 95
New York 78
Jacksonville 57
The Dalles 48
Munich 45
Ann Arbor 44
Los Angeles 40
Ho Chi Minh City 38
Verona 32
Lawrence 31
Princeton 31
Wilmington 28
Jinan 25
Shenyang 25
Nanjing 23
Seoul 22
Tianjin 22
Santa Clara 20
Hanoi 18
Turku 18
Tokyo 17
Columbus 15
Redondo Beach 15
Buffalo 13
Hebei 13
Houston 13
Denver 12
Guangzhou 12
London 12
Zhengzhou 12
Chennai 11
Sindelfingen 11
Changsha 10
São Paulo 9
Frankfurt am Main 8
Ningbo 8
Seattle 8
Mexico City 7
Orem 7
Rome 7
San Francisco 7
Stockholm 7
Amsterdam 6
Atlanta 6
Brooklyn 6
Council Bluffs 6
Haikou 6
Hangzhou 6
Johannesburg 6
Milan 6
Nanchang 6
Taiyuan 6
Tashkent 6
Boston 5
Markgröningen 5
Redmond 5
Redwood City 5
Augusta 4
Cagliari 4
Campo Grande 4
Dearborn 4
Haiphong 4
Helsinki 4
Hải Dương 4
Lancaster 4
Meda 4
Montreal 4
Phoenix 4
Poplar 4
Rio de Janeiro 4
Shanghai 4
Taizhou 4
Thái Nguyên 4
Warsaw 4
Biên Hòa 3
Bologna 3
Clearwater 3
Cotonou 3
Detroit 3
Fremont 3
Fuzhou 3
Guayaquil 3
Istanbul 3
Jakarta 3
Jiaxing 3
Karachi 3
Kent 3
Lomé 3
Maceió 3
Manchester 3
Mountain View 3
Totale 2.840
Salva come PNG Salva come JPEG
Nome #
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 193
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer 189
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 184
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 183
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 182
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 173
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 167
Identification of clinical, pathological and molecular predictors of prognosis in early-stage invasive lobular breast cancer: role of proliferation and CDK4/6 pathway. 165
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives 162
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 160
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 153
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 153
Tubulin inhibitors in non-small cell lung cancer: looking back and forward 145
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival 139
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy 139
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting 139
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer 139
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research 136
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 134
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome 133
Putative predictors of efficacy for immune checkpoint inhibitors in non-small-cell lung cancer: facing the complexity of the immune system. 130
Platelet-derived growth factor receptor inhibitors for non-small cell lung cancer: is the odyssey over? 127
Discordance in pathology report after central pathology review: Implications for breast cancer adjuvant treatment 124
Muscle derangement and alteration of the nutritional machinery in NSCLC 123
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 120
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis 117
Integrating the molecular background of targeted therapy and immunotherapy in lung cancer: a way to explore the impact of mutational landscape on tumor immunogenicity 115
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer 115
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 114
Avoiding chemotherapy for advanced nononcogene addicted NSCLC overexpressing PD-L1: Rule or option? 111
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 103
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 97
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 95
The obesity paradox in cancer: clinical insights and perspectives 92
Tracking MET de-addiction in lung cancer: A road towards the oncogenic target. 80
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 45
Totale 4.876
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.951
article - articoli 16.004
book - libri 0
conference - conferenze 518
curatela - curatele 0
other - altro 429
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 19 2 2 7 5 26 6
2021/2022269 20 92 0 33 11 3 3 8 13 6 15 65
2022/2023645 36 90 39 134 57 151 3 37 64 1 20 13
2023/2024355 14 24 16 27 54 75 7 32 10 34 55 7
2024/2025812 38 33 44 158 26 38 16 20 138 56 86 159
2025/20261.763 178 103 150 452 743 137 0 0 0 0 0 0
Totale 4.876